Radient Technologies Inc
XTSX:RTI

Watchlist Manager
Radient Technologies Inc Logo
Radient Technologies Inc
XTSX:RTI
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 2.7m CAD

Relative Value

RTI doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of RTI.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RTI Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.9
Median 5Y
0.9
Industry
2.5
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
21.6
vs History
vs Industry
Median 3Y
10.8
Median 5Y
10.8
Industry
16.7
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
24
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
2.2
vs History
vs Industry
Median 3Y
1.4
Median 5Y
1.4
Industry
2.7
vs History
vs Industry
Median 3Y
-36.8
Median 5Y
-36.8
Industry
5.3
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
12.9
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.7
Industry
16.3
vs History
vs Industry
Median 3Y
18.1
Median 5Y
18.1
Industry
15.2
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-4.6
Industry
17.7
vs History
vs Industry
Median 3Y
1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

RTI Competitors Multiples
Radient Technologies Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Radient Technologies Inc
XTSX:RTI
2.7m CAD 0.9 -0.2 -0.9 -0.7
US
Eli Lilly and Co
NYSE:LLY
721.7B USD 14.7 65 34.9 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
392.1B USD 4.4 18 13.1 17.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.2 18 12.5 14.3
CH
Roche Holding AG
SIX:ROG
204.4B CHF 3.4 24.7 9.3 10.9
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 17.7 10.5 14
UK
AstraZeneca PLC
LSE:AZN
159.9B GBP 3.9 27.6 130.6 196.9
US
Merck & Co Inc
NYSE:MRK
205.1B USD 3.2 11.8 8.7 10.6
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.7B USD 2.2 17.7 7.6 10.7
P/E Multiple
Earnings Growth PEG
CA
Radient Technologies Inc
XTSX:RTI
Average P/E: 25.1
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
65
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
18
27%
0.7
DK
Novo Nordisk A/S
CSE:NOVO B
18
18%
1
CH
Roche Holding AG
SIX:ROG
24.7
32%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.6
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Radient Technologies Inc
XTSX:RTI
Average EV/EBITDA: 436.6
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.9
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.1
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.5
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.6
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Radient Technologies Inc
XTSX:RTI
Average EV/EBIT: 1 874.8
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.2
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.3
14%
1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.9
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1